Janus Henderson Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Hold |
10,071
| – | – | ﹤0.01% | 1459 |
|
|
2025
Q1 | $1.85M | Hold |
10,071
| – | – | ﹤0.01% | 1319 |
|
|
2024
Q4 | $1.58M | Buy |
10,071
+1,400
| +16% | +$219K | ﹤0.01% | 1437 |
|
|
2024
Q3 | $1.58M | Hold |
8,671
| – | – | ﹤0.01% | 1426 |
|
|
2024
Q2 | $1.59M | Sell |
8,671
-125
| -1% | -$23K | ﹤0.01% | 1364 |
|
|
2024
Q1 | $1.57M | Hold |
8,796
| – | – | ﹤0.01% | 1400 |
|
|
2023
Q4 | $1.09M | Sell |
8,796
-12
| -0.1% | -$1.49K | ﹤0.01% | 1581 |
|
|
2023
Q3 | $1.02M | Buy |
8,808
+14
| +0.2% | +$1.63K | ﹤0.01% | 1548 |
|
|
2023
Q2 | $1.03M | Sell |
8,794
-17
| -0.2% | -$2K | ﹤0.01% | 1602 |
|
|
2023
Q1 | $706K | Buy |
8,811
+4,287
| +95% | +$343K | ﹤0.01% | 1824 |
|
|
2022
Q4 | $358K | Buy |
+4,524
| New | +$358K | ﹤0.01% | 1892 |
|
|
2022
Q2 | – | Sell |
-4,304
| Closed | -$286K | – | 2639 |
|
|
2022
Q1 | $286K | Buy |
4,304
+1,395
| +48% | +$92.7K | ﹤0.01% | 2251 |
|
|
2021
Q4 | $204K | Buy |
+2,909
| New | +$204K | ﹤0.01% | 2385 |
|